Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone lysis and inflammation.

D R Haynes1

  • 1University of Adelaide, Adelaide, South Australia 5005. david.haynes@adelaide.edu.au

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]
|February 8, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontitis and Rheumatoid Arthritis: A Review.

Journal of periodontology·2018
Same author

Histone deacetylases (HDAC) in physiological and pathological bone remodelling.

Bone·2016
Same author

The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes.

Journal of periodontal research·2015
Same author

Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss.

Acta biomaterialia·2015
Same author

Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue.

Journal of periodontal research·2015
Same author

Caffeic acid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis.

Calcified tissue international·2015
Same journal

Single-cell profiling reveals clonal CD8<sup>+</sup>T cell-derived IFNγ drives Sjögren's disease-related dacryoadenitis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same journal

From acute mast cell activation to a structured immunothrombotic and autoimmune niche in chronic spontaneous urticaria.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same journal

Lipopolysaccharide promotes rheumatoid arthritis by enhancing Wnt7b mediated macrophage-FLS communication.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same journal

Unanswered questions on palmitic acid-driven neuroimmune inflammation in atopic dermatitis: a commentary on Chen et al.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same journal

Pathway-level proteomics identifies subcellular trafficking dysregulation as a molecular signature in severe traumatic brain injury.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same journal

Endothelial cell-specific knockout of ATG5 ameliorates inflammation and renal fibrosis by regulating pyroptosis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
See all related articles

Receptor activator NFkappaB (RANK), its ligand RANKL, and osteoprotegerin (OPG) are key regulators of osteoclast formation and bone loss. Targeting these molecules offers potential for treating inflammatory bone diseases.

Area of Science:

  • Bone biology and immunology
  • Cellular and molecular mechanisms of bone resorption

Background:

  • Osteoclast formation and activity are crucial for bone remodeling.
  • Recent advances have elucidated key molecular regulators of osteoclastogenesis.

Purpose of the Study:

  • To summarize the critical roles of RANK, RANKL, and OPG in normal bone physiology and disease-associated bone loss.
  • To highlight the therapeutic potential of targeting the RANK/RANKL/OPG pathway for inflammatory bone diseases.

Main Methods:

  • Review of current literature on osteoclast biology and the RANK/RANKL/OPG system.
  • Analysis of the molecular interactions governing osteoclast formation and bone resorption.

Main Results:

  • Receptor activator NFkappaB (RANK), its ligand RANKL, and the inhibitor osteoprotegerin (OPG) are central to osteoclast regulation.

Related Experiment Videos

  • The RANK/RANKL/OPG axis is implicated in bone loss in inflammatory conditions like rheumatoid arthritis and periodontal disease.

    • Conclusions:

    • The RANK/RANKL/OPG pathway is a fundamental regulator of bone homeostasis.
    • Pharmacological targeting of this pathway presents a promising strategy for managing severe bone loss in inflammatory diseases.